Keeping an eye on prescription drugs, keeping Canadians safe
Text Size: Normal / Medium / Large
Printer-friendly versionResource Language:
English
Media Type:
Online
Finds that testing for safety and effectiveness of prescrption drugs in Canada takes place almost exclusively before medications are approved and that there are “few regulatory obligations once a product reaches the market.”Assesses the Canadian post-market systems of drug surveillance - “pharmacovigilance” - and finds that there is no national system to test drugs for safety after they reach the market.
Available From:
Order Information:
Contact their office to order a copy. Also available online
ISBN/ISSN:
ISBN 978-1-897463-84-0 PDF
ISBN 978-1-897463-85-7 Print
URLs:
Notes:
Includes bibliographical references.
The Canadian Women's Health Network and the Centres of Excellence for Women's Health program are financially supported by Health Canada through the Women's Health Contribution Program. The views herein do not necessarily represent the official policy of Health Canada.